Diabetes Mellitus (DM) is a multi-factorial chronic health condition that affects a large part of
population and according to the World Health Organization (WHO) the number of adults …

Ethnopharmacological relevance Globally 387 million people currently have diabetes and it
is projected that this condition will be the 7th leading cause of death worldwide by 2030. As …

Background α-amylase and α-glucosidase digest the carbohydrates and increase the
postprandial glucose level in diabetic patients. Inhibiting the activity of these two enzymes …

Nature is a rich source of medicinal plants and their products that are useful for treatment of
various diseases and disorders. Momordica charantia, commonly known as bitter melon or …

In recent years, many studies of Momordica charantia (MC) in the treatment of diabetes
mellitus (DM) and its complications have been reported. This article reviewed the effect and …

α-Glucosidase inhibitor has considerable potential as a diabetes mellitus type 2 drug
because it prevents the digestion of carbohydrates. The search for the constituents reducing …

Diabetes mellitus (DM), a chronic metabolic disease, severely affects patients' life and
intensively increases risks of developing other diseases. It is estimated that 0.4 billion …

Recently, there is a paradigm shift that the whole food-derived components are not 'idle
bystanders' but actively participate in modulating aberrant metabolic and signaling pathways …

Momordica charantia L.(Cucurbitaceae), commonly known as bitter gourd or bitter melon, is
widely cultivated in many tropical and subtropical regions of the world, where its unripe fruits …

Momordica charantia fruits are used as a vegetable in many countries. From time
immemorial, it has also been used for management of diabetes in the Ayurvedic and …